158 related articles for article (PubMed ID: 9425325)
1. Prognostic value of MIB-1 in advanced ovarian carcinoma as determined using automated immunohistochemistry and quantitative image analysis.
Layfield LJ; Saria EA; Berchuck A; Dodge RK; Thompson JK; Conlon DH; Kerns BJ
J Surg Oncol; 1997 Dec; 66(4):230-6; discussion 236-7. PubMed ID: 9425325
[TBL] [Abstract][Full Text] [Related]
2. Determination of proliferation index with MIB-1 in advanced ovarian cancer using quantitative image analysis.
Kerns BJ; Jordan PA; Faerman LL; Berchuck A; Bast RC; Layfield LJ
Am J Clin Pathol; 1994 Feb; 101(2):192-7. PubMed ID: 8116574
[TBL] [Abstract][Full Text] [Related]
3. Quantitative image analysis of MIB-1 immunoreactivity. A comparison with flow cytometric assessment of proliferative activity in invasive carcinoma of the breast.
Ostrowski ML; Chakraborty S; Laucirica R; Brown RW; Greenberg SD
Anal Quant Cytol Histol; 1995 Feb; 17(1):15-24. PubMed ID: 7766265
[TBL] [Abstract][Full Text] [Related]
4. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
[TBL] [Abstract][Full Text] [Related]
5. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
6. DNA ploidy and p53 expression correlate with survival and cell proliferative activity in male breast carcinoma.
Pich A; Margaria E; Chiusa L; Ponti R; Geuna M
Hum Pathol; 1996 Jul; 27(7):676-82. PubMed ID: 8698311
[TBL] [Abstract][Full Text] [Related]
7. Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas.
Stanton KJ; Sidner RA; Miller GA; Cummings OW; Schmidt CM; Howard TJ; Wiebke EA
Am J Surg; 2003 Nov; 186(5):486-92. PubMed ID: 14599612
[TBL] [Abstract][Full Text] [Related]
8. Comparative prognostic value of Ki-67 and MIB-1 proliferation indices in breast cancer.
Veronese SM; Maisano C; Scibilia J
Anticancer Res; 1995; 15(6B):2717-22. PubMed ID: 8669852
[TBL] [Abstract][Full Text] [Related]
9. Transformation in recurrent ovarian granulosa cell tumors: Ki67 (MIB-1) and p53 immunohistochemistry demonstrates a possible molecular basis for the poor histopathologic prediction of clinical behavior.
Costa MJ; Walls J; Ames P; Roth LM
Hum Pathol; 1996 Mar; 27(3):274-81. PubMed ID: 8600043
[TBL] [Abstract][Full Text] [Related]
10. The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract.
Chowdhury GM; Kojima K; Kanayama H; Tsuji M; Kurokawa Y; Kagawa S
Cancer; 1996 Aug; 78(4):827-33. PubMed ID: 8756378
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of MIB-1 index and DNA ploidy in resectable ampulla of Vater carcinoma.
Shyr YM; Su CH; Wu LH; Li AF; Chiu JH; Wu CW; Lui WY
Ann Surg; 1999 Apr; 229(4):523-7. PubMed ID: 10203085
[TBL] [Abstract][Full Text] [Related]
12. Determination of proliferation index in advanced ovarian cancer using quantitative image analysis.
Jordan PA; Kerns BJ; Pence JC; Kohler MF; Bast RC; Kinney RB; Berchuck A
Am J Clin Pathol; 1993 Jun; 99(6):736-40. PubMed ID: 8322710
[TBL] [Abstract][Full Text] [Related]
13. Poly(adenosine diphosphate-ribose) polymerase expression in serous ovarian carcinoma: correlation with p53, MIB-1, and outcome.
Brustmann H
Int J Gynecol Pathol; 2007 Apr; 26(2):147-53. PubMed ID: 17413981
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of DNA ploidy and proliferative index (MIB-1 index) in gastrointestinal stromal tumors.
Carrillo R; Candia A; Rodriguez-Peralto JL; Caz V
Hum Pathol; 1997 Feb; 28(2):160-5. PubMed ID: 9023396
[TBL] [Abstract][Full Text] [Related]
15. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
Shyr YM; Su CH; Li AF; Wu CW; Lui WY
Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the proliferation index in gastric carcinomas with the monoclonal antibody MIB 1.
Broll R; Mahlke C; Best R; Schimmelpenning H; Strik MW; Schiedeck T; Bruch HP; Duchrow M
J Cancer Res Clin Oncol; 1998 Jan; 124(1):49-54. PubMed ID: 9498835
[TBL] [Abstract][Full Text] [Related]
17. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
18. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A
J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666
[TBL] [Abstract][Full Text] [Related]
19. Proliferation (MIB-1 expression) in oligodendrogliomas: assessment of quantitative methods and prognostic significance.
Coleman KE; Brat DJ; Cotsonis GA; Lawson D; Cohen C
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):109-14. PubMed ID: 16540741
[TBL] [Abstract][Full Text] [Related]
20. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples.
Sallinen PK; Haapasalo HK; Visakorpi T; Helén PT; Rantala IS; Isola JJ; Helin HJ
J Pathol; 1994 Dec; 174(4):275-82. PubMed ID: 7884589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]